Previous studies, including those by the authors, have reported that in gynaecological malignancies, such as epithelial ovarian cancers and uterine serous cancers, the altered expression of the p53 isoforms was associated with tumour traits, such as grade of differentiation, sensitivity to chemotherapy and survival23–26. The gene discussed is TP53; the disease is ovarian carcinoma.